Immune System News and Research

RSS

First genome sequences of SARS-CoV-2 viruses in Austria openly available

The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna.

3 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

New molecular mechanism that regulates the sentinel cells of the immune system

A study suggests that it may be possible to regulate macrophages with drugs that modulate the nuclear receptor RXR.

3 Apr 2020

Therapeutic cooling could mitigate damage to concussed cells

In the future, treating a concussion could be as simple as cooling the brain.

2 Apr 2020

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

Study investigates if the body's immune response to infections changes with seasons

Ground breaking new research is underway at the University of Surrey in collaboration with Columbia University to investigate if the body's immune response to infectious diseases and viruses, such as COVID-19, is altered by different seasons.

2 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.

1 Apr 2020

New collaboration may lead to future clinical trials to test treatment for leukemia

In a new pre-clinical study published this week in the journal Leukemia, the research team of Children's Hospital Los Angeles investigator Hisham Abdel-Azim, MD, MS, worked with colleagues to engineer T-cells to identify and target multiple sites on acute lymphoblastic leukemia cells instead of just one. The early collaboration points the way to future clinical trials to test the therapy.

1 Apr 2020

Stem cells used to combat COVID-19 pneumonia

The novel coronavirus first emerged in December 2019, and since then, it rippled across 180 countries, affecting hundreds of thousands of people. Amid the coronavirus disease (COVID-19) pandemic, many people are looking for answers. Scientists are racing to find a treatment that can help save lives. Now, a team of scientists has suggested that stem cell therapy can help fight the deadly infection.

1 Apr 2020

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

The European Research Council (ERC) has announced it will support Professor Thomas Blankenstein to the tune of €2.5 million over five years. This year the ERC is awarding Advanced Grants to a total of 158 scientists across Europe.

1 Apr 2020

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Amid the coronavirus disease (COVID-19) pandemic, many theories have emerged about the disease and the treatments that can in supportive care. A recent theory emerged that suggests non-steroidal anti-inflammatory drugs (NSAIDs) might exacerbate the symptoms of the novel coronavirus. Now, a new study shows that there is no evidence for or against the use of NSAIDS, particularly ibuprofen, for patients with COVID-19.

1 Apr 2020

FDA nod for first experimental plasma therapy for COVID-19 in the U.S.

The coronavirus disease (COVID-19) global pandemic has rapidly spread across the globe, now affecting 180 countries and territories. The United States is the front runner with the highest number of confirmed cases, surpassing both China, Italy, and Spain in the case toll. With the vast spread of the novel coronavirus, scientists and health experts are opting for varied treatments in the hope of helping ailing patients infected with COVID-19.

31 Mar 2020

New children's book 'Battle Robots of the Blood' released

Immunology expertise has combined with beautifully evocative illustrations to create an engaging book for children and their parents.

31 Mar 2020

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

When a virus invades the body, it leaves fingerprints behind. A research tool known as VirScan can detect this evidence - from just a single drop of blood - and identify the viruses that have infected a person in the past. Soon, the new coronavirus will join the VirScan lineup.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Individuals taking glucocorticoids are at high risk if infected with COVID-19

Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

31 Mar 2020

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Scientists have developed a new immunotherapy that eradicates solid tumors in mice without adverse side effects, according to a new study published today in eLife.

31 Mar 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

Immune System News and Research

First genome sequences of SARS-CoV-2 viruses in Austria openly available

St George's, University of London focuses entire research on tackling coronavirus

New molecular mechanism that regulates the sentinel cells of the immune system

Therapeutic cooling could mitigate damage to concussed cells

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Scientists find important clues to vaccine in SARS-CoV-2 genome

Study investigates if the body's immune response to infections changes with seasons

Putting an end to the pandemic

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

New collaboration may lead to future clinical trials to test treatment for leukemia

Stem cells used to combat COVID-19 pneumonia

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

FDA nod for first experimental plasma therapy for COVID-19 in the U.S.

New children's book 'Battle Robots of the Blood' released

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

Three Australian experts explain the course of COVID-19

Individuals taking glucocorticoids are at high risk if infected with COVID-19

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Immunology eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News